CARAMORI, GAETANO
 Distribuzione geografica
Continente #
AS - Asia 6.794
NA - Nord America 2.698
SA - Sud America 1.795
EU - Europa 1.053
AF - Africa 469
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.828
Nazione #
SG - Singapore 3.970
US - Stati Uniti d'America 2.503
BR - Brasile 1.405
HK - Hong Kong 861
CN - Cina 746
VN - Vietnam 675
ZA - Sudafrica 376
NL - Olanda 372
RU - Federazione Russa 183
AR - Argentina 169
IT - Italia 161
BD - Bangladesh 103
CA - Canada 79
DE - Germania 77
GB - Regno Unito 69
IN - India 68
EC - Ecuador 65
MX - Messico 64
IQ - Iraq 52
CO - Colombia 37
JP - Giappone 37
ID - Indonesia 35
PL - Polonia 35
VE - Venezuela 32
TR - Turchia 31
PK - Pakistan 29
AT - Austria 28
CL - Cile 27
UZ - Uzbekistan 27
PY - Paraguay 23
MA - Marocco 22
MY - Malesia 20
PE - Perù 18
UA - Ucraina 17
SE - Svezia 15
AE - Emirati Arabi Uniti 14
EG - Egitto 14
IR - Iran 14
AU - Australia 13
FI - Finlandia 13
KE - Kenya 13
JO - Giordania 12
TN - Tunisia 12
ES - Italia 11
UY - Uruguay 11
KR - Corea 10
NP - Nepal 10
FR - Francia 9
GT - Guatemala 9
BO - Bolivia 8
IE - Irlanda 8
LB - Libano 8
AL - Albania 7
AZ - Azerbaigian 7
HN - Honduras 7
KZ - Kazakistan 7
LT - Lituania 7
PA - Panama 7
SA - Arabia Saudita 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
CY - Cipro 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
OM - Oman 6
SN - Senegal 6
IL - Israele 5
AM - Armenia 4
AO - Angola 4
CR - Costa Rica 4
NI - Nicaragua 4
QA - Qatar 4
RO - Romania 4
RS - Serbia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
CG - Congo 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
HT - Haiti 2
JM - Giamaica 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
PR - Porto Rico 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AD - Andorra 1
Totale 12.805
Città #
Singapore 1.640
Hong Kong 860
Santa Clara 399
Boardman 361
Johannesburg 361
Dallas 291
Ho Chi Minh City 280
Ashburn 244
Los Angeles 172
Hanoi 136
Moscow 130
São Paulo 125
Beijing 112
Buffalo 72
Columbus 60
New York 56
Rio de Janeiro 50
Hefei 42
Shanghai 40
Brooklyn 37
Munich 37
Tokyo 36
Belo Horizonte 32
Warsaw 32
Nuremberg 29
Montreal 28
Brasília 26
Toronto 26
Milan 24
Parma 24
Tashkent 24
Hải Dương 22
Biên Hòa 21
Guarulhos 21
Haiphong 21
San Francisco 21
Guayaquil 20
Quito 20
Chennai 19
Fortaleza 19
Da Nang 18
Porto Alegre 18
Baghdad 17
Assago 16
Chicago 16
Curitiba 16
Mexico City 16
Phoenix 16
Denver 15
Guangzhou 15
Kuala Lumpur 14
London 14
Ribeirão Preto 14
Secaucus 14
Campinas 13
Dhaka 13
Lima 13
Thái Bình 13
Tianjin 13
Amman 12
Atlanta 12
Nairobi 12
Santiago 12
The Dalles 12
Caracas 11
Rio Claro 11
Stockholm 11
Sydney 11
Boston 10
Buenos Aires 10
Bắc Ninh 10
Changsha 10
Montevideo 10
Sorocaba 10
Volta Redonda 10
Ankara 9
Karachi 9
Lahore 9
Ninh Bình 9
Orem 9
Seoul 9
Vienna 9
Charlotte 8
Dublin 8
Duque de Caxias 8
Frankfurt am Main 8
Ha Long 8
Jinan 8
Lấp Vò 8
Manaus 8
Matelica 8
Medellín 8
Mumbai 8
Naples 8
Niterói 8
Quảng Ngãi 8
Santo André 8
Thái Nguyên 8
Uberlândia 8
Anápolis 7
Totale 6.634
Nome #
Onset of ANCA-positive EGPA with bilateral pleural effusion: a case report 107
Methotrexate in the treatment of systemic glucocorticoid dependent severe persistent astma: a word of caution 97
Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease 81
Adverse roles of mast cell chymase-1 in COPD 74
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive 70
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 69
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 67
Airway obstruction in chronic obstructive pulmonary disease 66
A rare case of sudden blindness following mepolizumab withdrawal in EGPA 65
A case of fibrosing interstitial pneumonia 63
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 60
Posttranscriptional regulation of airway epithelial responses by the RNA binding protein AUF-1 60
Allergen Responses Modified by a GATA3 DNAzyme 60
Activation of NF-kappaB transcription factor in asthma death 60
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease 58
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 56
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 55
Poxviridae Pneumonia 55
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 55
Decreased T-lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease 55
FN3K expression in COPD: A potential comorbidity factor for cardiovascular disease 54
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 53
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 52
A link between lung injury and inflammatory myopathies: making the diagnosis 52
Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer 52
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive 51
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 51
Delivery systems e protocollo di Montreal 51
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 51
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 50
Ruolo delle chinine nella patologia polmonare dell'adulto 50
Clinical definition of COPD exacerbations and classification of their severity 50
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology 50
Pathology of Asthma 50
Marcatori infiammatori nella diagnosi e nel monitoraggio dell’ asma 50
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease (vol 7, e000714, 2020) 50
La teofillina nella BPCO: nuove prospettive (3° parte) 50
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 50
Molecular mechanisms of respiratory virus-induced inflammation 50
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 50
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 49
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 49
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 49
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 49
IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection 48
Mechanisms of respiratory virus-induced asthma exacerbations 48
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 48
Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study 48
Transcription Factors 48
Physiologic consequences of long-term inflammation 48
Alterations of humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease 47
Oxidants and asthma 47
Expression of heme-oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effects of inhaled corticosteroids 47
Stem Cells/Lung Organoids and Lung Rejuvenation in the Treatment of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 47
Transcription factors in asthma and COPD 47
Glucocorticoidi per via inalatoria nel trattamento della patologia polmonare dell’adulto 46
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 46
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations 46
Quality of life in asthma and COPD: is it measurable in primary care? 46
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 45
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 45
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview 45
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 45
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio 45
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer 45
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto 45
TRANSCRIPTION FACTORS Overview 44
Asma 44
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 44
COPD pathology in the small airways 44
Implementazione delle linee guida sull’asma bronchiale in Italia: l’opinione del medico di medicina generale 44
Gender and respiratory infections 44
New targets for drug development in asthma 43
Role of ATG4 Autophagy-Related Protein Family in the Lower Airways of Patients with Stable COPD 43
Pathophysiology of viral-induced exacerbations of COPD 43
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 42
Anatomia e fisiologia clinica della pleura 42
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare 42
Donna non fumatrice con asma bronchiale difficile da controllare 42
Molecular links between COPD and lung cancer: new targets for drug discovery? 42
Trattamento del pneumotorace 42
Sintesi delle nuove linee guida internazionali per la terapia farmacologica dell’asma 41
An unusual cause of chest pain 41
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia 41
The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment 41
Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease 41
RNA-Binding Proteins as a Molecular Link between COPD and Lung Cancer 41
Role of viral infections in asthma exacerbations 41
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 41
Stato dell’arte degli antileucotrienici nella terapia dell’asma 41
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 40
Controllo dell’asma e delle BPCO nella medicina Generale 40
Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages 40
Sport e inquinamento atmosferico 40
Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways (European Respiratory Journal (2010) 36, (1425-1435)) 40
Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis 40
Sex differences and disparities in cardiovascular outcomes of COVID-19 40
Chemokine receptor inhibitors as a novel option in treatment of asthma 40
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease 40
Neutrophils and asthma 40
Totale 4.982
Categoria #
all - tutte 61.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024943 0 0 0 0 343 30 43 6 21 97 103 300
2024/20255.140 21 401 373 28 525 400 120 120 945 684 341 1.182
2025/20267.111 865 1.474 1.862 1.144 1.633 133 0 0 0 0 0 0
Totale 13.194